MSD licenced the antibody-drug conjugate (ADC) therapy, sacituzumab tirumotecan,...
Shares in Merus rose by 15% in premarket trading, following the announcement of ...
Shares in the pharma company rose 40% in premarket trading.
The US FDA's EMDAC is set to hold a meeting to assess the benefit-risk profile o...
Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financin...
Affecting more than 162,000 patients worldwide, global clinical trials are resea...
The EC has approved Celltrion’s Omlyclo, an omalizumab biosimilar for reference ...
Biocon has entered an exclusive licence and supply agreement with Handok to comm...
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settleme...
Sperm is said to be the morphologically most diverse cell on Earth. This form of...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform f...
The clinical-stage biotech will share preliminary safety and efficacy data with ...
Maximizing natural light in buildings is popular and can save on energy costs. H...
Carbon dioxide is the greenhouse gas, singlehandedly responsible for 78% of the ...
WHAT: Mice administered raw milk samples from dairy cows infected with H5N1 infl...
Researchers at the U of A found self-identified small business owners on TikTok ...
